CXCL12 and cancer: The interrupted VEGF-VEGFR2 signaling is substituted by cancer-associated fibroblasts and tumor cells through the secretion of HGF, EGF, and SDF-1α, by inducing the expression of their corresponding receptors and by direct cell to cell interactions12–15.